COVID-19 vaccination intention and hesitancy: Mistrust on COVID-19 vaccine benefit a major driver for vaccine hesitancy among healthcare workers: a cross-sectional study in North India.


COVID-19 pandemic
COVID-19 vaccine hesitancy
health belief model
vaccine resistance
vaccine acceptance
intention to vaccinate
anti-vaccine attitude
herd immunity
vaccine mistrust


Background: The advent of an effective novel COVID-19 vaccine could extinguish the current devastating pandemic but the vaccine hesitancy is a hurdle for the public health system. Objective: This study estimated the COVID-19 vaccination intention and the determinants among the healthcare workers, the priority target group for the COVID-19 vaccine in India. Design: A web-based cross-sectional survey design was used in this study. Setting and participants: The study was conducted among the healthcare workers in Chandigarh, a union territory in North India, using a Snowball sampling technique. A total of 403 healthcare workers participated in the study between 2nd and 25th January 2021. Methods: The primary data collected were the intention to get vaccinated against the available COVID-19 vaccine and the concerns regarding the new vaccines. The attitude towards the novel COVID-19 vaccine was assessed using the developed Vaccine attitude examination scale. These questionnaires, which were delivered via WhatsApp, was filled by the participants over Google forms. Results: Among the 403 respondents surveyed, the majority (54.6%) reported they were definitely intended to get vaccinated against COVID-19, however, 7% expressed a resistance for inoculation with COVID-19 vaccination. The perceived susceptibility (aOR=0.511, CI 0.265-0.987) and severity of COVID-19 infection (aOR=0.551 CI 0.196-0.704) and not being concerned about the efficacy of new COVID-19 vaccines (aOR= 0.702 CI 1.109-26.55) were found to have the highest significant odds of intention to take the COVID-19 vaccine. The majority (62%) were concerned about the safety of the vaccine, in terms of side-effects, quality control, and doubted efficacy of the vaccine. The mistrust of the benefits of the vaccine is a significant predictor for vaccine hesitancy among the healthcare workers (aOR=5.205 CI 3.106-8.723). Conclusion: Therefore, strategic communication and vaccine-acceptance programs should be formulated in order to combat the prevailing mistrust on the vaccine safety and efficacy and attain effective coverage to gain herd immunity.


1. WHO. Weekly epidemiological update - 5 January 2021. Emergency Situational Updates. 5 January 2021. Available from
2. Foy BH, Wahl B, Mehta K, Shet A, Menon GI, Britto C. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study. Int J Infect Dis. 2020 Dec 31;103:431-438. doi: 10.1016/j.ijid.2020.12.075.
3. Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey. J Multidiscip Healthc. 2020 Nov 20;13:1657-1663. doi: 10.2147/JMDH.S276771. PMID: 33262600; PMCID: PMC7686470.
4. Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Saha RP, Lee -S-S. Extensive partnership, collaboration, and teamwork is required to stop the COVID-19 outbreak. Arch Med Res. 2020;51(7):728–730. doi:10.1016/j.arcmed.2020.05.021
5. Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W et al. Coronavirus Pandemic Epidemiology Consortium. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020 Sep;5(9):e475-e483. doi: 10.1016/S2468-2667(20)30164-X.
6. Jose S, Dhandapani M, Cyriac MC. Burnout and Resilience among Frontline Nurses during COVID-19 Pandemic: A Cross-sectional Study in the Emergency Department of a Tertiary Care Center, North India. Indian J Crit Care Med 2020;24(11):1081–1088.
7. Jose S, Cyriac MC, Dhandapani M. Health Problems and Skin Damages Caused by Personal Protective Equipment: Experience of Frontline Nurses Caring for Critical COVID-19 Patients in Intensive Care Units. Health Problems and Skin Damages Caused by Personal Protective Equipment: Experience of Frontline Nurses Caring for Critical COVID-19 Patients in Intensive Care Units. Indian J Crit Care Med. 2021; 24(2). Available from https://www.
8. Gupta M, Mohanta SS, Rao A, Parameswaran GG, Agarwal M, Arora M, Mazumder A, Lohiya A, Behera P, Bansal A, Kumar R, Meena VP, Tiwari P, Mohan A, Bhatnagar S. Transmission dynamics of the COVID-19 epidemic in India and modeling optimal lockdown exit strategies. Int J Infect Dis. 2020 Dec 3;103:579-589. doi: 10.1016/j.ijid.2020.11.206.
9. Jose S, Cyriac MC, Dhandapani M, Mehra A, Sharma N. Mental health outcomes of perceived stress, anxiety, fear, and insomnia, and the resilience among frontline nurses caring for critical COVID-19 patients in intensive care units. Open J Psychiatry Allied Sci. Forthcoming 2021.
10. Foy BH, Wahl B, Mehta K, Shet A, Menon GI, Britto C. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study. Int J Infect Dis. 2020 Dec 31;103:431-438. doi: 10.1016/j.ijid.2020.12.075.
11. Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.
12. Graham BS. Rapid COVID-19 vaccine development. Science. 2020 May 29;368(6494):945-946. doi: 10.1126/science.abb892.
13. MacDonald NE, Butler R, Dubé E. Addressing barriers to vaccine acceptance: an overview. Hum Vaccin Immunother. 2018 Jan 2;14(1):218-224. doi: 10.1080/21645515.2017.1394533. Epub 2017 Nov 29. PMID: 29048975; PMCID: PMC5791591.
14. Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2020 Oct 27;21(2):e26–35. doi: 10.1016/S1473-3099(20)30773-8. Epub ahead of print. PMID: 33125914; PMCID: PMC7837315.
15. Seale H, Heywood AE, McLaws ML, Ward KF, Lowbridge CP, Van D, MacIntyre CR. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis. 2010 Apr 19;10:99. doi: 10.1186/1471-2334-10-99. PMID: 20403201; PMCID: PMC2864274.
16. Rubin GJ, Potts HW, Michie S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK. Health Technol Assess. 2010 Jul;14(34):183-266. doi: 10.3310/hta14340-03. PMID: 20630124.
17. Eastwood K, Durrheim DN, Jones A, Butler M. Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med J Aust. 2010 Jan 4;192(1):33-6. doi: 10.5694/j.1326-5377.2010.tb03399.x. PMID: 20047546.
18. Wang, Q.; Yue, N.; Zheng, M.; Wang, D.; Duan, C.; Yu, X.; Zhang, X.; Bao, C.; Jin, H. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis. Vaccine 2018, 36, 7262–7269.
19. Dubé, E.; MacDonald, N.E. Vaccine Acceptance: Barriers, Perceived Risks, Benefits, and Irrational Beliefs. In The Vaccine Book, 2nd ed.; Bloom, B.R., Lambert, P., Eds.; Academic Press: Cambridge, MA, USA, 2016; Chapter 26; pp. 507–528.
20. Larson, H.J.; Jarrett, C.; Eckersberger, E.; Smith, D.M.D.; Paterson, P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature. Vaccine 2014, 32, 2150–2159.
21. Henrich, N.; Holmes, B. The public’s acceptance of novel vaccines during a pandemic: A focus group study and its application to influenza H1N1. Emerg. Health Threat. J. 2009, 2, 7088.
22. Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961. doi: 10.1371/journal.pntd.0008961.
23. Champion VL, Skinner CS. The health belief model In Glanz K., Rimer B. K., & Viswanath K. (Eds.), Health behavior and health education: Theory, research, and practice (p. 45–65). Jossey-Bass; 2008

24. Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, Ng RWY, Lai CKC, Boon SS, Lau JTF, Chen Z, Chan PKS. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021 Jan 6:S0264-410X(20)31695-9. doi: 10.1016/j.vaccine.2020.12.083. Epub ahead of print. PMID: 33461834; PMCID: PMC7832076.

25. Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020 Oct 20:1–4. doi: 10.1038/s41591-020-1124-9. Epub ahead of print. Erratum in: Nat Med. 2021 Jan 11;: PMID: 33082575; PMCID: PMC7573523.

26. Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R; SAGE Working Group on Vaccine Hesitancy. Measuring vaccine hesitancy: The development of a survey tool. Vaccine. 2015 Aug 14;33(34):4165-75. doi: 10.1016/j.vaccine.2015.04.037. Epub 2015 Apr 18. PMID: 25896384.

27. Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020 Aug;35(8):775-779. doi: 10.1007/s10654-020-00671-y. Epub 2020 Aug 12. PMID: 32785815.
28. Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine. 2018 Jan 29;36(5):660-667. doi: 10.1016/j.vaccine.2017.12.043.
29. Martin LR, Petrie KJ. Understanding the Dimensions of Anti-Vaccination Attitudes: the Vaccination Attitudes Examination (VAX) Scale. Ann Behav Med. 2017 Oct;51(5):652-660. doi: 10.1007/s12160-017-9888-y.
30. MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015 Aug 14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036. Epub 2015 Apr 17. PMID: 25896383.
31. Gagneux-Brunon A, Detoc M, Bruel S, Tardy B, Rozaire O, Frappe P, Botelho-Nevers E. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey. J Hosp Infect. 2021 Feb;108:168-173. doi: 10.1016/j.jhin.2020.11.020. Epub 2020 Nov 28. PMID: 33259883; PMCID: PMC7699157.
32. Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961. doi: 10.1371/journal.pntd.0008961. PMID: 33332359; PMCID: PMC7775119.
33. Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020 Sep 1;16(9):2204-2214. doi: 10.1080/21645515.2020.1790279
34. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020 Dec 15;173(12):964-973. doi: 10.7326/M20-3569.
35. Fine P, Eames K, Heymann DL. "Herd immunity": a rough guide. Clin Infect Dis. 2011 Apr 1;52(7):911-6. doi: 10.1093/cid/cir007. PMID: 21427399.
36. Alimohamadi Y, Taghdir M, Sepandi M. Estimate of the Basic Reproduction Number for COVID-19: A Systematic Review and Meta-analysis. J Prev Med Public Health. 2020 May;53(3):151-157. doi: 10.3961/jpmph.20.076.
37. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013 Aug;9(8):1763-73. doi: 10.4161/hv.24657. Epub 2013 Apr 12. PMID: 23584253; PMCID: PMC3906279.
38. Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020 Sep;21(7):977-982. doi: 10.1007/s10198-020-01208-6. PMID: 32591957; PMCID: PMC7317261.
39. Torreele E. The rush to create a covid-19 vaccine may do more harm than good. BMJ. 2020 Aug 18;370:m3209. doi: 10.1136/bmj.m3209.
40. Corey BL, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368:948–50
41. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10. PMID: 33301246; PMCID: PMC7745181.
42. Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, Rubin GJ, Sevdalis N. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2020 Nov 26:1-10. doi: 10.1080/21645515.2020.1846397. Epub ahead of print. PMID: 33242386.